Nanexa AB (publ) (STO:NANEXA)
Sweden · Delayed Price · Currency is SEK 3.715
+0.195 (5.54%)
Mar 25, 2026, 3:18 PM CET
Nanexa AB Market Cap
Nanexa AB has a market cap or net worth of 579.34 million as of March 25, 2026. Its market cap has increased by 223.44% in one year.
Market Cap
579.34M
Enterprise Value
535.89M
Revenue
55.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.72
Market Cap Chart
Since June 17, 2015, Nanexa AB's market cap has increased from 49.07M to 579.34M, an increase of 1,080.56%. That is a compound annual growth rate of 25.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 625.42M | -11.43% |
| Dec 30, 2025 | 706.11M | 140.91% |
| Dec 30, 2024 | 293.10M | 292.61% |
| Dec 29, 2023 | 74.66M | -46.84% |
| Dec 30, 2022 | 140.43M | -30.75% |
| Dec 30, 2021 | 202.78M | -19.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.39B |
| Cereno Scientific AB | 1.97B |
| EQL Pharma AB | 1.54B |
| Dicot Pharma AB | 872.05M |
| Cinclus Pharma Holding AB | 803.24M |
| Orexo AB | 781.58M |
| Enzymatica AB | 555.86M |
| Moberg Pharma AB | 493.51M |